John Shanahan Email

Director Research, Development, and Engineering . Hemostasis

Current Roles

Employees:
46
Revenue:
$11.5M
About
Designs and manufactures advanced technology for hemostasis, specifically advanced blood clotting technology. NexStat Topical Hemostat Powder is intended for use under the care of a health care professional as a topical dressing for the temporary treatment of moderate to severely bleeding wounds such as surgical wounds (post-operative, donor sites, dermatological), cuts and lacerations and for the treatment of mild bleeding from topical ENT surgical wounds and nosebleeds. It is also indicated for control of bleeding from the skin at percutaneous needle access, vascular and percutaneous catheter access sites. NexFoam is a versatile sponge that can be used as a spacer, stent and hemostat. It dissolves naturally over 7-14 days or can be easily removed with gentle irrigation. Both NexStat and NexFoam are biocompatible and require no special storage conditions.
Hemostasis Address
5000 Township Parkway
Saint Paul, MN
United States
Hemostasis Email

Past Companies

Hemostasis, LLCDirector Of Research, Development, and Engineering
Hemostasis, LLCSenior Principal Engineer
PentairSenior Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.